Abstract:Each of the three BAFF receptors (BCMA, TACI and BR3) has a non‐redundant role in determining the ultimate lymphocyte profile of the host, including the distribution of B cell subsets and the expansion of Foxp3+ cells. This may have clinically relevant ramifications in that the degree that a candidate therapeutic agent blocks engagement of any given individual BAFF receptor may affect its clinical utility. BAFF, a vital B cell survival and differentiation factor, has three receptors: B‐cell maturation antigen (BCMA), transmembrane activator and CAML interactor (TACI) and BR3. Although B cells are greatly reduced in B6.Baff−/− (which harbour no BAFF) and B6.Br3−/− mice (which harbour supra‐normal levels of BAFF), the distributions of B cell subsets and relationships between Foxp3+ and CD4+ cells in these mice differ. Using a large panel of B6 congenic knockout and/or transgenic mice, we demonstrate that (1) supra‐normal levels of BAFF per se do not explain the phenotypic differences between B6.Baff−/− and B6.Br3−/− mice; (2) B cells are expanded in B6.Taci−/− mice, with preferential expansion of follicular (FO) B cells at the expense of CD19+CD21−/loCD23−/lo B cells but without the preferential expansion of Foxp3+ cells observed in B6 mice bearing a Baff transgene; (3) despite no expansion in total B cells, percentages of FO B cells and marginal zone B cells are higher and percentages of CD19+CD21−/loCD23−/lo B cells are lower in young B6.Bcma−/− mice, consistent with the inability of B6.Br3−/−.Taci−/− mice to recapitulate the B cell profile of B6.Baff−/− mice; and (4) percentages of Foxp3+ cells in B6.Br3−/−.Taci−/− mice are intermediate between those in B6.Br3−/− and B6.Taci−/− mice despite the B cell profile of B6.Br3−/−.Taci−/− mice strongly resembling that of B6.Br3−/− mice. Collectively, our findings point to a non‐redundant role for each of the BAFF receptors in determining the ultimate lymphocyte profile of the host. This may have clinically relevant ramifications in that the degree that a candidate therapeutic agent blocks engagement of any given individual BAFF receptor may affect its clinical utility.

Identify the Key Amino Acid of BAFF Binding with TACI.

Molecular Mechanism of the Affinity Interactions Between Baff and Its Peptides by Molecular Simulations

Molecular Mechanism of the Selectivity Between BAFF/APRIL and Their Receptors by Molecular Simulations

BAFF antagonists designed by computer-aided drug design inhibited the interaction of BAFF with its receptors

Molecular Structure, Expression, and Bioactivity of B-cell-activating Factor of the TNF Family (BAFF) and Its Receptor BAFF-R in Cats (felis Catus).

Molecular dynamics simulation and analysis of BAFF which is incorporated with p-nitro-L-phenylalanine

Expression,purification and bioactivity identification of recombinant human BAFF fusion protein

Preparation and bioactivity characterization of recombinant human soluble mutant BAFF

BAFF Binding to T Cell‐expressed BAFF‐R Costimulates T Cell Proliferation and Alloresponses

Molecular structure, bioinformatics analysis, expression and bioactivity of BAFF (TNF13B) in dog (Canis familiaris).

Molecular Cloning, Expression, Bioinformatics Analysis and Bioactivity Characterization of Tnf13b (baff) Gene in Bat (vespertilio Superans Thomas)

Distinct Binding Mode of BAFF Antagonist Antibodies Belimumab and Tabalumab, Analyzed by Computer Simulation

B Cell Activating Factor (baff) Induces the Transcription of Recombination-Activating Genes in Transitional Stage 1 B Cells

BAFF Binding to T Cell-Expressed BAFF-R Promotes Follicular Helper T Cell Proliferation and GC B Cell Responses

Effect of Rhtaci-Ig Fusion Protein on Antigen-Specific T Cell Responses from Keyhole Limpet Haemocyanin Challenged Mice

Contributions of each of the BAFF receptors to the lymphocyte profiles in C57BL/6 mice

Study on the Mechanism of Selective Interaction of BR3 and BCMA with BAFF and APRIL.

Molecular structure, expression, and function analysis of BAFF gene in Chinese sucker, Myxocyprinus asiaticus

Ligand–receptor binding revealed by the TNF family member TALL-1

Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas

BAFF promotes follicular helper T cell development and germinal center formation through BR3 signal